Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$166M Buy
1,014,000
+25,540
+3% +$3.93M 9.43% 2
2025
Q4
$172M Sell
988,460
-32,540
-3% -$5.94M 7.92% 3
2025
Q3
$147M Buy
1,021,000
+301,000
+42% +$36.9M 7.84% 2
2025
Q2
$72.5M Buy
720,000
+270,000
+60% +$20.6M 3.76% 8
2025
Q1
$34.3M Buy
450,000
+171,000
+61% +$13.1M 4.31% 6
2024
Q4
$19.3M Buy
279,000
+181,460
+186% +$13.1M 0.85% 25
2024
Q3
$7.12M Buy
+97,540
New +$7.2M 0.19% 27

Other funds holding INSM

NWI Management's INSM Position: Q1 2026 in Review

NWI Management increased its Insmed (INSM) stake by 2.6% in Q1 2026, buying an estimated $3.93M and bringing the position to 1,014,000 shares worth $166M. The position accounts for 9.43% of the portfolio, ranked #2.

NWI Management first reported a position in INSM in Q3 2024 and has held it in 7 quarters since. The position peaked at $172M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • NWI Management held 1,014,000 shares of Insmed worth $166M as of Q1 2026.
  • NWI Management bought 25,540 Insmed shares in Q1 2026, an estimated $3.93M.
  • Insmed made up 9.43% of NWI Management's portfolio in Q1 2026, its #2 holding.
  • NWI Management first reported a position in Insmed in Q3 2024 and has held it in 7 quarters since.
  • NWI Management's Insmed position peaked at $172M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on NWI Management's 13F filing for Q1 2026, filed 15 May 2026.